Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Journal of Medicinal Chemistry
|
June 25, 2005
Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity
Nicolas Foloppe, Lisa M Fisher, Rob Howes, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 13, 2009
Discovery and functional evaluation of diverse novel human CB(1) receptor ligands
Nicolas Foloppe, Karen Benwell, Teresa D Brooks, et al.
Bioorganic & Medicinal Chemistry
|
May 1, 2010
Virtual screening, selection and development of a benzindolone structural scaffold for inhibition of lumazine synthase
Arindam Talukdar, Ekaterina Morgunova, Jianxin Duan, et al.
Journal of the American Chemical Society
|
May 7, 2013
Quantum mechanics/molecular mechanics modeling of regioselectivity of drug metabolism in cytochrome P450 2C9
Richard Lonsdale, Kerensa T Houghton, Jolanta Żurek, et al.
Plos Computational Biology
|
April 12, 2014
rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids
Sergio Ruiz-Carmona, Daniel Alvarez-Garcia, Nicolas Foloppe, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 18, 2007
Discovery of a novel class of selective human CB1 inverse agonists
Nicolas Foloppe, Nicola H Allen, Carol H Bentley, et al.
Oncotarget
|
October 6, 2015
Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design
Andrew J Massey, Stephen Stokes, Helen Browne, et al.
Molecular Microbiology
|
September 14, 2012
Mycoredoxin-1 is one of the missing links in the oxidative stress defence mechanism of Mycobacteria
Koen Van Laer, Lieven Buts, Nicolas Foloppe, et al.
Journal of Medicinal Chemistry
|
June 18, 2021
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B
David Lee Walmsley, James B Murray, Pawel Dokurno, et al.
Journal of Medicinal Chemistry
|
May 12, 2021
Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors
Csaba Weber, Melinda Sipos, Attila Paczal, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Journal of Medicinal Chemistry
|
June 25, 2005
Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity
Nicolas Foloppe, Lisa M Fisher, Rob Howes, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 13, 2009
Discovery and functional evaluation of diverse novel human CB(1) receptor ligands
Nicolas Foloppe, Karen Benwell, Teresa D Brooks, et al.
Bioorganic & Medicinal Chemistry
|
May 1, 2010
Virtual screening, selection and development of a benzindolone structural scaffold for inhibition of lumazine synthase
Arindam Talukdar, Ekaterina Morgunova, Jianxin Duan, et al.
Journal of the American Chemical Society
|
May 7, 2013
Quantum mechanics/molecular mechanics modeling of regioselectivity of drug metabolism in cytochrome P450 2C9
Richard Lonsdale, Kerensa T Houghton, Jolanta Żurek, et al.
Plos Computational Biology
|
April 12, 2014
rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids
Sergio Ruiz-Carmona, Daniel Alvarez-Garcia, Nicolas Foloppe, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 18, 2007
Discovery of a novel class of selective human CB1 inverse agonists
Nicolas Foloppe, Nicola H Allen, Carol H Bentley, et al.
Oncotarget
|
October 6, 2015
Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design
Andrew J Massey, Stephen Stokes, Helen Browne, et al.
Molecular Microbiology
|
September 14, 2012
Mycoredoxin-1 is one of the missing links in the oxidative stress defence mechanism of Mycobacteria
Koen Van Laer, Lieven Buts, Nicolas Foloppe, et al.
Journal of Medicinal Chemistry
|
June 18, 2021
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B
David Lee Walmsley, James B Murray, Pawel Dokurno, et al.
Journal of Medicinal Chemistry
|
May 12, 2021
Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors
Csaba Weber, Melinda Sipos, Attila Paczal, et al.
Page
of 6